Join leading regulatory experts from Japan, Singapore, and South Korea for a webinar exploring CGT approval pathways across three key APAC jurisdictions. Based on the recently published ISCT APAC Industry Committee regulatory roadmap in Cytotherapy, this session provides practical insights for navigating complex regional regulatory landscapes. Our distinguished panelists will share emerging trends and recent updates in APAC cell and gene therapy regulations, including regulated access to unapproved and unproven therapies and real-world case studies from their respective markets. Learn about Singapore's risk-based CTGTP classification system, Japan's innovative conditional approval pathways, and South Korea's advanced biological products regulations. This is a must-attend webinar for regulatory affairs professionals, clinical developers, and business leaders seeking to unlock APAC opportunities while ensuring alignment between Eastern and Western regulatory approaches. Tune in for actionable insights that propels successful approval strategies, information on submission requirements, and development timelines that can accelerate your CGT programs in these rapidly expanding markets.

Achieving consistent and effective outcomes in CAR T and other immune effector cell (IEC) therapies relies heavily on getting lymphodepletion “right.” Emerging evidence shows that both under- and over-exposure can impact safety, efficacy, and long-term persistence, making optimized dosing strategies increasingly critical as the field evolves. This webinar will explore how model-informed and data-driven approaches can help identify the optimal lymphodepletion exposure window, improve predictability, and support more standardized practices across patient populations and treatment centers. Speakers will discuss current challenges, scientific rationale, clinical insights, and practical considerations for implementation.

The ISCT North America Regional Executive Committee invites you to join your ISCT peers and colleagues for an interactive, member-focused North America Regional Town Hall.

The ISCT Asia Regional Executive Committee invites you to join your ISCT peers and colleagues for an interactive, member-focussed Asia Regional Town Hall.

Business Development and Finance

Asia Regional Executive Committee Webinar on September 3, 2025

This webinar, Emerging Cell and Gene Therapy Approaches for Knee Osteoarthritis, will provide participants with an up-to-date overview of how advanced cell and gene therapy (CGT) modalities are being developed to address unmet clinical needs in knee osteoarthritis. The program integrates scientific, translational, and clinical perspectives to highlight emerging disease-modifying strategies beyond conventional symptomatic treatments. By the end of this webinar, participants will be able to understand the biological rationale for CGT in knee osteoarthritis, including mechanisms related to cartilage degeneration, inflammation, and impaired tissue repair; compare emerging cell-based platforms, such as mesenchymal stromal cells, iPSC-derived products, and extracellular vesicles, with respect to mechanism of action and translational potential; and recognize key gene therapy strategies being explored for local joint delivery. Participants will also gain insight into critical manufacturing, clinical trial, and regulatory considerations that influence the development, evaluation, and future adoption of CGT-based therapies for knee osteoarthritis.

Member Exclusive: ISCT ESP Mentoring Program Kick-Off Call

This webinar will explore the emerging role of induced pluripotent stem cells (iPSCs) in musculoskeletal research and regenerative medicine. Participants will gain insight into iPSCs, with a focus on their application in treating musculoskeletal diseases. The session will highlight recent advances, technical challenges, and ethical considerations associated with translating iPSC technology into clinical practice.

Join us for the ISCT MMST Educational Webinar on "Visible Particulates in Cell and Gene Therapy: Challenges and Perspectives in Risk Assessment," scheduled for November 13, 2025. This session, sponsored by Gateway Analytical, seeks to explore the unique challenges posed by visible particulates in low-unit cell and gene therapy (CGT) batches. As regulatory concerns mount and traditional standards fall short, our expert panel will share insights from various stakeholders, including manufacturers, service providers, and regulatory consultants. Discover the operational impacts of lot rejection, learn about best practices for managing particulate risk, and delve into regulatory expectations. This webinar will focus on practical strategies and best practices while providing actionable approaches for managing visible particulates. Participants will gain valuable insights into navigating these challenges in their work, ultimately leading to improved outcomes in cell and gene therapy manufacturing. Join us to engage with industry leaders, identify knowledge gaps, and contribute to a dialogue that prioritizes patient safety while addressing the complexities of CGT manufacturing. Don't miss this opportunity to be part of an essential conversation shaping the future of cell and gene therapy quality standards!